4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000030
CEO bought 160,774 shares at an average $0.01 ($1,904)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
19 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-07 | Purchase : show line 1 in the form | +10,000 | $0.01 | $124 | 21,602,123 | D |
| 2019-05-07 | Purchase : show line 2 in the form | +10,000 | $0.01 | $120 | 21,612,123 | D |
| 2019-05-08 | Purchase : show line 3 in the form | +10,000 | $0.01 | $115 | 21,622,123 | D |
| 2019-05-08 | Purchase : show line 4 in the form | +10,000 | $0.01 | $116 | 21,632,123 | D |
| 2019-05-08 | Purchase : show line 5 in the form | +20,000 | $0.01 | $238 | 21,652,123 | D |
| 2019-05-08 | Purchase : show line 6 in the form | +2,000 | $0.01 | $23 | 21,654,123 | D |
| 2019-05-08 | Purchase : show line 7 in the form | +2,000 | $0.01 | $23 | 21,656,123 | D |
| 2019-05-08 | Purchase : show line 8 in the form | +2,000 | $0.01 | $23 | 21,658,123 | D |
| Open-market purchases · 160,774 sh · avg $0.01 · $1,904 | ||||||
Loading xslF345X03/primary_doc.xml…